ABT241018C116000
- 2.22
- -0.22-9.02%
Abbott Laboratories Newsroom
Abbott Laboratories Analyst Ratings
Goldman Sachs Remains a Buy on Abbott Laboratories (ABT)
Abbott Laboratories (ABT) Gets a Buy From Piper Sandler
Analysts Offer Insights on Healthcare Companies: Resmed (RMD) and Abbott Laboratories (ABT)
Morgan Stanley Adjusts Price Target on Abbott Laboratories to $117 From $107, Maintains Equalweight Rating
Express News | Abbott : Piper Sandler Raises Target Price to $133 From $131
Abbott Laboratories (ABT) Q3 2024 Earnings Call Highlights: Strong Growth in Diabetes Care and ...
Why Abbott Laboratories Stock Was a Winner on Wednesday
Stifel Maintains Abbott Laboratories(ABT.US) With Buy Rating, Raises Target Price to $130
Jefferies Maintains Abbott Laboratories(ABT.US) With Hold Rating, Raises Target Price to $125
Cautious Outlook on Abbott Laboratories Amid Mixed Financials and Legal Challenges
Abbott Laboratories: Strong Growth Prospects and Strategic Positioning Drive Buy Rating
Earnings Call: Abbott Reports 8% Organic Sales Growth, Raises Guidance
BTIG Maintains Abbott Laboratories(ABT.US) With Buy Rating, Raises Target Price to $139
Abbott Stock Gains on Q3 Earnings Beat, Margins Expand
Tech Stocks Stall, Small Caps Surge As Regional Banks Rally, Airlines Rocket: What's Driving Markets Wednesday?
Is Your Smartwatch Boosting Med Tech Stocks? -- Barrons.com
Sector Update: Health Care
10 Health Care Stocks With Whale Alerts In Today's Session
Abbott Laboratories (ABT) Q3 2024 Earnings Call Transcript Summary